Description
Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂, produced by solid-phase peptide synthesis. It contains the unnatural residues alpha-aminoisobutyric acid (Aib) and 2-naphthylalanine, two D-amino acid substitutions, and a C-terminal amide.
It was identified in the 1990s from a series of compounds built around the growth hormone-releasing peptide scaffold. In published literature, ipamorelin has been characterized as a ligand of the growth hormone secretagogue receptor subtype 1a (GHS-R1a), the receptor for ghrelin, and it is distinguished within its class by reported selectivity for that receptor relative to earlier GHRP-scaffold compounds. That selectivity makes it a frequent reference ligand in growth hormone secretagogue pharmacology.
This material is supplied as a characterized reference compound for non-clinical laboratory work, such as analytical method development, GHS-R1a receptor binding and cAMP or calcium-flux assays, somatotroph cell culture assays, and comparative structure-activity and selectivity studies across the GHRP series.
Compound Specifications
| Property | Value |
| Amino Acid Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH₂ |
| Sequence Length | 5 residues (pentapeptide) |
| Molecular Formula | C₃₈H₄₉N₉O₅ |
| Molecular Weight | ~711.9 g/mol |
| Monoisotopic Mass | 711.3857 Da |
| CAS Number | 170851-70-4 |
| Physical Form | Lyophilized powder |
Storage & Handling
Store lyophilized powder at −20 °C, protected from light. Avoid moisture and repeated freeze-thaw cycles. Handle in accordance with standard laboratory safety practices.
FOR RESEARCH USE ONLY. Not for human consumption. Not intended for human or veterinary use. For laboratory research and analytical purposes only.

